Tag: Bribery

Compliance After China’s Healthcare Bribery Scandals

Changing everyday business practices instead of focusing only on legal issues may help companies comply with Chinese anti-corruption laws. By Benjamin Shobert and Damjan DeNoble  In the aftermath of this summer’s bribery scandals involving pharmaceutical firms GlaxoSmithKline (GSK), Sanofi S.A....

/ October 10, 2013